Currently out of the existing stock ratings of David Rescott, 98 are a BUY (85.96%), 16 are a HOLD (14.04%).

David Rescott

Work Performance Price Targets & Ratings Chart

Analyst David Rescott, currently employed at TRUIST, carries an average stock price target met ratio of 63.65% that have a potential upside of 22% achieved within 120 days. Previously, David Rescott worked at BAIRD.

David Rescott’s has documented 243 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PEN, Penumbra at 11-Apr-2025.

Wall Street Analyst David Rescott

Analyst best performing recommendations are on EW (EDWARDS LIFESCIENCES CORP).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 10/31/2024. The price target of $85 was fulfilled within 5 days with a profit of $12.56 (17.34%) receiving and performance score of 34.68.

Average potential price target upside

of $100.35 (71.27%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $59.88 (15.81%) on ISRG (INTUITIVE SURGICAL).
of $41.09 (19.12%) on PEN (PENUMBRA).

MDT Medtronic PLC NVRO Nevro Corp PEN Penumbra IRTC iRhythm Technologies IRT Independence Realty Trust AXNX Axonics Modulation Technologies SIBN Si-Bone BSX Boston Scientific Corp INSP Inspire Medical Systems ISRG Intuitive Surgical LIVN LivaNova PLC NARI Inari Medical EW Edwards Lifesciences Corp MMSI Merit Medical Systems

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Richard Newitter (TRUIST)